Ulivi P - Search Results

1

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

Ulivi P, Zoli W, Calistri D, Fabbri F, Tesei A, Rosetti M, Mengozzi M, Amadori D. Ulivi P, et al. J Cell Physiol. 2006 Mar;206(3):611-5. doi: 10.1002/jcp.20503. J Cell Physiol. 2006. PMID: 16222700

2

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

Ricotti L, Tesei A, De Paola F, Ulivi P, Frassineti GL, Milandri C, Amadori D, Zoli W. Ricotti L, et al. Among authors: ulivi p. Clin Cancer Res. 2003 Feb;9(2):900-5. Clin Cancer Res. 2003. PMID: 12576465

3

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: ulivi p. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

4

Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells.

Ricotti L, Tesei A, De Paola F, Milandri C, Amadori D, Frassineti GL, Ulivi P, Zoli W. Ricotti L, et al. Among authors: ulivi p. J Chemother. 2003 Oct;15(5):480-7. doi: 10.1179/joc.2003.15.5.480. J Chemother. 2003. PMID: 14598941

5

Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.

Zoli W, Ricotti L, Tesei A, Ulivi P, Gasperi Campani A, Fabbri F, Gunelli R, Frassineti GL, Amadori D. Zoli W, et al. Among authors: ulivi p. Clin Cancer Res. 2004 Feb 15;10(4):1500-7. doi: 10.1158/1078-0432.ccr-1107-03. Clin Cancer Res. 2004. PMID: 14977854

6

c-kit and SCF expression in normal and tumor breast tissue.

Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R. Ulivi P, et al. Breast Cancer Res Treat. 2004 Jan;83(1):33-42. doi: 10.1023/B:BREA.0000010694.35023.9e. Breast Cancer Res Treat. 2004. PMID: 14997053

7

In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines.

Tesei A, Ulivi P, Fabbri F, Rosetti M, Leonetti C, Scarsella M, Zupi G, Amadori D, Bolla M, Zoli W. Tesei A, et al. Among authors: ulivi p. J Transl Med. 2005 Feb 3;3(1):7. doi: 10.1186/1479-5876-3-7. J Transl Med. 2005. PMID: 15691389 Free PMC article.

8

Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma models.

Ulivi P, Zoli W, Fabbri F, Brigliadori G, Ricotti L, Tesei A, Rosetti M, De Cesare M, Beretta GL, Corna E, Supino R, Zunino F. Ulivi P, et al. Neoplasia. 2005 Feb;7(2):152-61. doi: 10.1593/neo.04397. Neoplasia. 2005. PMID: 15802020 Free PMC article.

9

Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines.

Rosetti M, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Granato AM, Amadori D, Zoli W. Rosetti M, et al. Among authors: ulivi p. Cancer Biol Ther. 2005 Oct;4(10):1089-95. doi: 10.4161/cbt.4.10.1995. Epub 2005 Oct 7. Cancer Biol Ther. 2005. PMID: 16082196 Free article.

10

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.

Fabbri F, Brigliadori G, Ulivi P, Tesei A, Vannini I, Rosetti M, Bravaccini S, Amadori D, Bolla M, Zoli W. Fabbri F, et al. Among authors: ulivi p. Apoptosis. 2005 Oct;10(5):1095-103. doi: 10.1007/s10495-005-0619-7. Apoptosis. 2005. PMID: 16151642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters